Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-15-080280
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-16 16:21:01
Reporting Period:
2015-11-12
Filing Date:
2015-11-16
Accepted Time:
2015-11-16 16:21:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1371217 Enteromedics Inc ETRM Electromedical & Electrotherapeutic Apparatus (3845) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1243513 B Mark Knudson 2800 Patton Road
St. Paul MN 55113
Chrmn, Pres & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-11-12 310,000 $0.16 613,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,382 Indirect Spouse Revocable Trust
Common Stock 3,215 Indirect Family Limited Partnership
Common Stock 57,571 Indirect Revocable Trust 2003
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $2.76 2015-04-27 7,915 7,915 Direct
Common Stock Stock Option (right to buy) $2.76 2016-04-20 6,776 6,776 Direct
Common Stock Stock Option (right to buy) $1.90 2010-10-29 2017-10-29 33,432 33,432 Direct
Common Stock Stock Option (right to buy) $1.90 2010-10-29 2017-10-29 25,902 25,902 Direct
Common Stock Stock Option (right to buy) $1.90 2010-10-29 2017-10-29 44,131 44,131 Direct
Common Stock Stock Option (right to buy) $1.90 2010-10-29 2017-10-29 50,472 50,472 Direct
Common Stock Stock Option (right to buy) $3.78 2019-11-18 20,833 20,833 Direct
Common Stock Warrant (common stock right to buy) $2.19 25,000 25,000 Direct
Common Stock Stock Option (right to buy) $2.58 2011-03-16 2021-02-16 350,000 350,000 Direct
Common Stock Stock Option (right to buy) $2.67 2011-08-12 2021-07-12 350,000 350,000 Direct
Common Stock Stock Option (right to buy) $1.90 2012-01-14 2021-12-14 200,000 200,000 Direct
Common Stock Stock Option (right to buy) $3.35 2012-08-10 2022-07-10 1,292,225 1,292,225 Direct
Common Stock Stock Option (right to buy) $1.31 2013-06-30 2013-05-31 1,278,730 1,278,730 Direct
Common Stock Stock Option (right to buy) $1.11 2015-04-09 2025-03-09 225,000 225,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-04-27 7,915 7,915 Direct
2016-04-20 6,776 6,776 Direct
2017-10-29 33,432 33,432 Direct
2017-10-29 25,902 25,902 Direct
2017-10-29 44,131 44,131 Direct
2017-10-29 50,472 50,472 Direct
2019-11-18 20,833 20,833 Direct
25,000 25,000 Direct
2021-02-16 350,000 350,000 Direct
2021-07-12 350,000 350,000 Direct
2021-12-14 200,000 200,000 Direct
2022-07-10 1,292,225 1,292,225 Direct
2013-05-31 1,278,730 1,278,730 Direct
2025-03-09 225,000 225,000 Direct
Footnotes
  1. The price reported is the weighted average purchase price for the transaction reported. The purchase prices ranged from $0.15 to $0.18. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range.
  2. Options currently 100% vested.
  3. Options vest 33% on date noted and thereafter at 1/24th per month.
  4. Warrant becomes exercisable 181 days from the date of issuance at close of offering.
  5. Warrant expires five years from the date it becomes exercisable.
  6. Vests in increments of 1/48th per month, beginning the date shown.
  7. The exercise price is the closing price on July 10, 2012, the date the board authorized the grants subject to stockholder approval of the increase in the number of shares available for awards under the incentive plan, which was obtained on September 27, 2012.